Cagent Vascular

The RECOIL BTK Study has been published in the Journal of Endovascular Therapy! This groundbreaking study demonstrated a statistically significant difference between BTK lesions treated with #Serranator (6% recoil) and Plain Balloon (55% recoil). 

pubmed.ncbi.nlm.nih.gov/38059463/

Cagent Vascular will be at CARVE 2025 this week in Park City, Utah. Stop by our booth to learn about the #Serranator and how it can help optimize treatment for the entire leg. #CARVE #ClinicallyRelevant #VascularSpecialist

Join Dr. Peter Schneider on Thursday as he moderates a discussion on the advances in pedal interventions for difficult CLTI patients with Dr. Edward Gifford and Dr. Mike Watts. Sign up today: hubs.ly/Q0360sVS0

Join Cagent Vascular and these renowned physicians for our webinar on using #Serranator for ATK & BTK Interventions.
Learn about implementing Serranator into your practice with this webinar on February 6th. Register here: lnkd.in/eJZAKzv6

Dr. Ravin treated a CTO in the SFA using a 5x120mm #Serranator. Serration angioplasty provided excellent lumen gain utilizing low pressure prior to a DCB. No dissection and excellent blood flow was observed.

#PAD #Angioplasty #VascularHealth #CriticalLimbsaving